Exelixis, Inc. (EXEL)
58.39
+0.45
(+0.78%)
USD |
NASDAQ |
Oct 02, 16:00
58.37
-0.02
(-0.03%)
After-Hours: 20:00
Exelixis Profit Margin (Quarterly) : 33.73% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.73% |
| March 31, 2026 | 34.46% |
| December 31, 2025 | 40.85% |
| September 30, 2025 | 32.38% |
| June 30, 2025 | 32.53% |
| March 31, 2025 | 28.74% |
| December 31, 2024 | 24.68% |
| September 30, 2024 | 21.87% |
| June 30, 2024 | 35.49% |
| March 31, 2024 | 8.78% |
| December 31, 2023 | 17.83% |
| September 30, 2023 | 0.22% |
| June 30, 2023 | 17.28% |
| March 31, 2023 | 9.79% |
| December 31, 2022 | -7.12% |
| September 30, 2022 | 17.78% |
| June 30, 2022 | 16.85% |
| March 31, 2022 | 19.26% |
| December 31, 2021 | 21.09% |
| September 30, 2021 | 11.63% |
| June 30, 2021 | 24.95% |
| March 31, 2021 | 0.59% |
| December 31, 2020 | 10.51% |
| September 30, 2020 | -13.86% |
| June 30, 2020 | 25.75% |
| Date | Value |
|---|---|
| March 31, 2020 | 21.42% |
| December 31, 2019 | 28.61% |
| September 30, 2019 | 35.87% |
| June 30, 2019 | 32.90% |
| March 31, 2019 | 35.16% |
| December 31, 2018 | |
| September 30, 2018 | 56.18% |
| June 30, 2018 | 47.01% |
| March 31, 2018 | 54.56% |
| December 31, 2017 | 32.06% |
| September 30, 2017 | 53.18% |
| June 30, 2017 | 17.77% |
| March 31, 2017 | 20.58% |
| December 31, 2016 | 45.27% |
| September 30, 2016 | -18.14% |
| June 30, 2016 | -96.10% |
| March 31, 2016 | -383.9% |
| December 31, 2015 | -418.3% |
| September 30, 2015 | -482.7% |
| June 30, 2015 | -542.6% |
| March 31, 2015 | -374.6% |
| December 31, 2014 | -788.2% |
| September 30, 2014 | -994.4% |
| June 30, 2014 | -1.12K% |
| March 31, 2014 | -1.52K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| Cytokinetics, Inc. | -694.4% |
| Emergent BioSolutions, Inc. | -76.91% |
| Gilead Sciences, Inc. | -134.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 42.46% |
| Return on Assets | 31.94% |
| Return on Invested Capital | 39.02% |
| Gross Profit Margin (Quarterly) | 96.71% |
| Operating Margin (Quarterly) | 39.51% |
| Return on Net Operating Assets | 162.5% |